Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis

Area of Science:

• Proteomics
• Cancer Biology
• Biomarker Discovery

Background:

• Quantitative proteomics is crucial for identifying disease-related molecular changes.
• Selecting the optimal quantification strategy for clinical samples remains a challenge.
• High-resolution proteomics enables comprehensive cell proteome characterization.

Purpose of the Study:

• To compare label-free (intensity-based) and 8-plex iTRAQ quantitative proteomics strategies.
• To evaluate these methods for analyzing bladder cancer tumor tissue.
• To determine the best strategy for identifying biologically relevant protein expression changes.

Main Methods:

• Analysis of non-muscle invasive and muscle-invasive bladder cancer tissues.
• Comparison of label-free versus 8-plex iTRAQ quantification.
• Testing iTRAQ with both unfractionated and fractionated peptides.
• Validation against existing datasets (Protein Atlas, published literature).

Main Results:

• Label-free identified 910 proteins, fractionated iTRAQ 1092, and unfractionated iTRAQ 332.
• Label-free offered higher protein sequence coverage than iTRAQ.
• Label-free detected a greater number of significant differentially expressed proteins.
• Both methods showed agreement with existing bladder cancer data.

Conclusions:

• Label-free and iTRAQ (with fractionation) offer high proteome coverage and valid differential expression predictions.
• Label-free proteomics provides superior sequence coverage and identifies more differentially expressed proteins.
• Careful method selection and consideration of sample heterogeneity are vital for robust clinical proteomics findings.